Abera Bioscience AB (NGM:ABERA)
Sweden · Delayed Price · Currency is SEK 6.56
-0.04 (-0.61%)
At close: May 25, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 134.47 million as of May 26, 2026. Its market cap has increased by 3.05% in one year.
Market Cap
134.47M
Enterprise Value
108.43M
Revenue
11.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.56
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 134.47M, an increase of 16.34%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 138.98M | 10.80% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prolight Diagnostics AB | 186.69M |
| Fable Media Group AB | 184.80M |
| EmbeddedArt Group AB | 174.37M |
| Seamless Distribution Systems AB | 163.15M |
| Xer Tech Holding AB | 158.20M |
| Solution International Nordics AB | 155.88M |
| Nowonomics AB | 140.88M |
| Aquaticus Real Estate AB | 129.98M |